Covered recipient · General Payments record
MATTHEW P GOETZ
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2019–2025
$136,263.34
- Reported across 112 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $34,220.00 | 12 |
| Food and Beverage | $614.75 | 5 |
| Travel and Lodging | $29.30 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $18,000.00 | 4 |
| Genentech, Inc. | $4,620.00 | 3 |
| Eli Lilly and Company | $4,159.53 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $3,286.52 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $2,613.00 | 2 |
| Acerta Pharma LLC | $2,185.00 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $135.00 | 06/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207043373 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,050.00 | 07/08/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1206166310 | CMS |
| Eli Lilly and Company | $800.00 | 06/20/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186752737 | CMS |
| Eli Lilly and Company | $3,200.00 | 10/09/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186776338 | CMS |
| Eli Lilly and Company | $29.30 | 10/23/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1186776340 | CMS |
| Eli Lilly and Company | $125.00 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186802109 | CMS |
| Eli Lilly and Company | $5.23 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186837921 | CMS |
| Genentech, Inc. | $3,800.00 | 02/18/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1211547049 | CMS |
| Genentech, Inc. | $410.00 | 12/02/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1211547045 | CMS |
| Genentech, Inc. | $410.00 | 12/02/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1211547053 | CMS |
| Lilly USA, LLC | $3,200.00 | 11/17/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186767334 | CMS |
| Lilly USA, LLC | $3,200.00 | 11/17/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186802111 | CMS |
| Lilly USA, LLC | $3,200.00 | 11/17/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186815117 | CMS |
| Lilly USA, LLC | $8,400.00 | 11/19/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186837923 | CMS |
| Novartis Pharmaceuticals Corporation | $136.52 | 05/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200288974 | CMS |
| Novartis Pharmaceuticals Corporation | $3,150.00 | 05/31/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1200288976 | CMS |
| PUMA BIOTECHNOLOGY, INC. | $2,400.00 | 12/09/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1251743448 | CMS |
| PUMA BIOTECHNOLOGY, INC. | $213.00 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251743450 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.